美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Hemab Therapeutics Holdings, Inc.

39.40

-0.4800-1.20%

盤後：39.400.00000.00%19:04 EDT

成交量：40.81萬

成交額：1,624.46萬

市值：18.40億

市盈率：-22.11

高：42.48

開：40.26

低：38.98

收：39.88

52周最高：55.42

52周最低：23.00

股本：4,670.54萬

流通股本：1,675.00萬

量比：1.14

換手率：2.44%

股息：- -

股息率：- -

每股收益(TTM):-1.7820

每股收益(LYR):-67.5613

淨資產收益率：-46.99%

總資產收益率：-30.11%

市淨率：4.05

市盈率(LYR):-0.58

資料載入中...

總覽公司新聞公告

美國研究綜述-卡迪納爾健康、盧門圖姆控股、公共倉儲

H.C. Wainwright 首次覆蓋 Hemab Therapeutics，給予「買入」評級及40美元目標價

美國研究綜述-阿波羅、菲利普斯66、瓦萊羅能源

諾和諾德基金會參投的生物科技公司Hemab(COAG.US)擬赴美IPO，最高募資2.12億美元

Hemab Therapeutics Holdings Inc提交SEC文件：預計IPO股價區間為16-18美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/COAG/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"COAG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","market":"US","secType":"STK","nameCN":"Hemab Therapeutics Holdings, Inc.","latestPrice":39.4,"timestamp":1789156800000,"preClose":39.88,"halted":0,"volume":408085,"hourTrading":{"tag":"盘后","latestPrice":39.4,"preClose":39.4,"latestTime":"19:04 EDT","volume":30,"amount":1182.69,"timestamp":1789167844018,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.012036108324975025,"floatShares":16750000,"shares":46705400,"eps":-1.782,"marketStatus":"休市中","change":-0.48,"latestTime":"09-11 16:00:00 EDT","open":40.26,"high":42.4843,"low":38.98,"amount":16244562.05885,"amplitude":0.087871,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.782,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":39.88,"preHourTrading":{"tag":"盘前","latestPrice":40.44,"preClose":39.88,"latestTime":"09:29 EDT","volume":266,"amount":10645.0008,"timestamp":1789133399039,"change":0.56,"changeRate":0.014042,"amplitude":0.016299},"postHourTrading":{"tag":"盘后","latestPrice":39.4,"preClose":39.4,"latestTime":"19:04 EDT","volume":30,"amount":1182.69,"timestamp":1789167844018,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1449033520172376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","floatShares":16750000,"roa":"-30.11%","roe":"-46.99%","lyrEps":-67.56131,"volumeRatio":1.1449033520172376,"shares":46705400,"dividePrice":0,"high":42.4843,"amplitude":0.087871,"preClose":39.88,"low":38.98,"week52Low":23.0001,"pbRate":"4.05","week52High":55.42,"institutionHeld":0,"latestPrice":39.4,"eps":-1.782,"divideRate":0,"volume":408085,"delay":0,"ttmEps":-1.782,"open":40.26,"prevYearClose":18,"prevWeekClose":44.41,"prevMonthClose":45.73,"prevQuarterClose":36.73,"fiveDayClose":44.37,"twentyDayClose":53.95,"sixtyDayClose":25.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COAG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"COAG","fiscalQuarterEnding":"2026/06","expectedEps":-0.63,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COAG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COAG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1781755200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COAG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COAG","date":"2026-09-11","current":-22.109989,"percent":0.511111,"low":-34.170536,"twenty":-29.479949,"median":-23.509442,"eighty":-18.159648,"high":-11.042152,"avg":-23.686128,"sd":5.485186,"marketCap":1862879225},"quantilePoints":[{"date":"2026-05-01","current":-11.042152,"twenty":-11.042152,"median":-11.042152,"eighty":-11.042152,"marketCap":705737088},{"date":"2026-05-08","current":-17.79803,"twenty":-17.79803,"median":-17.407359,"eighty":-17.286354,"marketCap":1137525503},{"date":"2026-05-15","current":-19.616555,"twenty":-19.616555,"median":-17.521449,"eighty":-17.286354,"marketCap":1253752856},{"date":"2026-05-22","current":-18.185245,"twenty":-19.409118,"median":-17.853347,"eighty":-17.293269,"marketCap":1162273533},{"date":"2026-05-29","current":-19.360717,"twenty":-19.450605,"median":-18.046954,"eighty":-17.354117,"marketCap":1237401480},{"date":"2026-06-05","current":-17.56985,"twenty":-19.450605,"median":-18.185245,"eighty":-17.491025,"marketCap":1122941843},{"date":"2026-06-12","current":-18.627775,"twenty":-19.370397,"median":-18.1403,"eighty":-17.515917,"marketCap":1190556995},{"date":"2026-06-18","current":-18.288963,"twenty":-19.294337,"median":-18.002009,"eighty":-17.444006,"marketCap":1168902469},{"date":"2026-06-26","current":-18.159648,"twenty":-19.492093,"median":-18.185245,"eighty":-17.510385,"marketCap":1294673965},{"date":"2026-07-02","current":-21.291074,"twenty":-19.764526,"median":-18.302792,"eighty":-17.540809,"marketCap":1517925825},{"date":"2026-07-10","current":-24.370091,"twenty":-20.501011,"median":-18.714206,"eighty":-17.578148,"marketCap":1737441252},{"date":"2026-07-17","current":-29.172047,"twenty":-21.688778,"median":-18.837687,"eighty":-17.609955,"marketCap":2079791907},{"date":"2026-07-24","current":-30.02369,"twenty":-24.062189,"median":-19.305401,"eighty":-17.650059,"marketCap":2140508940},{"date":"2026-07-31","current":-31.09807,"twenty":-25.689482,"median":-19.512836,"eighty":-17.666654,"marketCap":2217105812},{"date":"2026-08-07","current":-34.170536,"twenty":-29.287346,"median":-19.706444,"eighty":-17.692929,"marketCap":2436154185},{"date":"2026-08-14","current":-30.277152,"twenty":-30.021629,"median":-19.996854,"eighty":-17.818774,"marketCap":2520118712},{"date":"2026-08-21","current":-27.050208,"twenty":-30.064832,"median":-20.629413,"eighty":-17.903131,"marketCap":2251524039},{"date":"2026-08-28","current":-27.774166,"twenty":-30.021629,"median":-21.296443,"eighty":-17.946001,"marketCap":2311782670},{"date":"2026-09-04","current":-24.900782,"twenty":-29.906697,"median":-22.201677,"eighty":-18.108214,"marketCap":2072616631},{"date":"2026-09-11","current":-22.38096,"twenty":-29.479949,"median":-23.509442,"eighty":-18.159648,"marketCap":1862879225}],"updateTime":1789338207514},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COAG\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658927621","title":"美國研究綜述-卡迪納爾健康、盧門圖姆控股、公共倉儲","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927621","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927621?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 16:08","pubTimestamp":1786522123,"startTime":"0","endTime":"0","summary":"美国研究综述-卡迪纳尔健康、卢门图姆控股、公共仓储路透8月12日-周三，华尔街证券分析师调整了多家在美国上市公司的评级和目标股价，其中包括卡迪纳尔健康、卢门图姆控股和公共仓储。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4S4490GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACVA","HLIO","SR","ANF","TGT","REIT","RPD","CAH","MNST","CRCL","CVS","COAG","LBRX","NEM","MDLN","SGMT","ACM","CUBE","MIDD","CANC","URBN","FLUT","NTRA","CRWV","PSA","GAP","BCAX","VTR","CAVA","UMAC","LITE","PNW","AMBQ","EGGY","EXR","LEGN","BLCK","LOW","JBIO","HD","LENZ","MAA","TXG","USFD","BBIO","MRCY","NEMG","LPTH","JAZZ","WELL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183732399","title":"H.C. Wainwright 首次覆蓋 Hemab Therapeutics，給予「買入」評級及40美元目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1183732399","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183732399?lang=zh_tw&edition=fundamental","pubTime":"2026-06-17 18:08","pubTimestamp":1781690902,"startTime":"0","endTime":"0","summary":"投资机构 H.C. Wainwright 近日启动了对 Hemab Therapeutics Holdings, Inc. 的研究覆盖，并给予了“买入”评级。该机构为这家生物技术公司设定了每股40美元的目标价格。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638473599","title":"美國研究綜述-阿波羅、菲利普斯66、瓦萊羅能源","url":"https://stock-news.laohu8.com/highlight/detail?id=2638473599","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638473599?lang=zh_tw&edition=fundamental","pubTime":"2026-05-26 15:32","pubTimestamp":1779780727,"startTime":"0","endTime":"0","summary":"美国研究综述-阿波罗、菲利普斯66、瓦莱罗能源路透5月26日 - 周二，华尔街证券分析师调整了多家在美国上市公司的评级和目标股价，其中包括阿波罗、菲利普斯66和瓦莱罗能源。股票条目按字母顺序排列。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nL4T4230EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU0630314457.HKD","LU0300736062.USD","IE00B19Z3581.USD","MPC","PS","IE00BZ1G4Q59.USD","TKR","BJ","ALNT","LU1861214812.USD","BK4161","CGNX","IE00B775SV38.USD","VLO","ALBG","LU0274383776.USD","SPTX","BAH","BK4138","HLIO","AD","LU2106854487.HKD","LU0456854461.SGD","LU0477156953.USD","LU0266013472.USD","LU1169589451.USD","PSX","LU0205194284.USD","LU1206713676.USD","LU0266512127.USD","BK4548","LU0096364046.USD","APO","RRX","ALB","LU0345780950.USD","LU1201861249.SGD","LU0130517989.USD","BK4139","LU0980610538.SGD","COAG","LU1803068623.USD","TDS","BK4155","BK4157","BK4585","TTAN","LU0266512473.USD","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630437375","title":"諾和諾德基金會參投的生物科技公司Hemab(COAG.US)擬赴美IPO，最高募資2.12億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630437375","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630437375?lang=zh_tw&edition=fundamental","pubTime":"2026-04-28 16:00","pubTimestamp":1777363239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物科技公司Hemab Therapeutics Holdings Inc.正寻求在美国首次公开募股中最高融资2.12亿美元。此次生物科技公司IPO的背景是，投资者对减肥药物开发商Kailera Therapeutics Inc.给予了热烈反响——该公司于本月初上市，募资7.19亿美元，创下2021年以来该行业在美国最大的IPO记录。招股文件还显示，在本次发行前，RA Capital Management的关联实体与诺和诺德基金会分别持有Hemab 18%和15%的股份。截至2025年12月31日，公司持有现金及现金等价物共1.85亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0154236417.USD","BK4007","COAG","BK4581","IE00BZ1G4Q59.USD","NVO","BK4532","IE00BKVL7J92.USD","BK4599","LU1093756325.SGD","BK4588","NVOH","BK4585","LU1093756168.USD","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195572245","title":"Hemab Therapeutics Holdings Inc提交SEC文件：預計IPO股價區間為16-18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195572245","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195572245?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 19:22","pubTimestamp":1777288965,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会（SEC）的文件显示，生物制药公司Hemab Therapeutics Holdings Inc首次公开募股（IPO）的初步定价区间已确定为每股16美元至18美元。\n这一价格区间标志着该公司正式迈出登陆公开资本市场的关键一步。若按此区间上限计算，此次IPO有望为Hemab Therapeutics募集可观的资金，用于推进其创新疗法的研发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}